Phase II study of cediranib in patients with malignant pleural mesothelioma: SWOG S0509.

Autor: Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman M, Gandara DR, Garland, Linda L, Chansky, Kari, Wozniak, Antoinette J, Tsao, Anne S, Gadgeel, Shirish M, Verschraegen, Claire F, Dasilva, Marco A, Redman, Mary, Gandara, David R

Publikováno v: Journal of Thoracic Oncology; 2011 Nov, Vol. 6 Issue 11, p1938-1945, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.

Autor: Bixby B; Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of Arizona, Tucson, USA., Vrba L; Precision Epigenomics, Tucson, AZ, USA., Lenka J; Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of Arizona, Tucson, USA., Oshiro MM; Boyer Liver Institute, Department of Medicine, University of Arizona, Tucson, USA., Watts GS; Department of Pharmacology and Toxicology, University of Arizona, Tucson, USA., Hughes T; Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of Arizona, Tucson, USA., Erickson H; Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of Arizona, Tucson, USA., Chopra M; Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of Arizona, Tucson, USA., Knepler JL; Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of Arizona, Tucson, USA., Knox KS; Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of Arizona, Phoenix, USA., Jarnagin L; Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of Arizona, Phoenix, USA., Alalawi R; Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of Arizona, Phoenix, USA., Kala M; Department of Internal Medicine, University of Arizona, Phoenix, USA., Bernert R; Precision Epigenomics, Tucson, AZ, USA., Routh J; Midwestern University, Glendale, USA., Roe DJ; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, USA., Garland LL; Hematology Oncology, Department of Medicine, University of Arizona, Tucson, USA., Futscher BW; Department of Pharmacology and Toxicology, University of Arizona, Tucson, USA., Nelson MA; Department of Pathology, University of Arizona, Tucson, AZ, 85724, USA. manelson@arizona.edu.

Publikováno v: Scientific reports [Sci Rep] 2024 Feb 05; Vol. 14 (1), pp. 2939. Date of Electronic Publication: 2024 Feb 05.

Developing an ACT-based intervention to address lung cancer stigma: Stakeholder recommendations and feasibility testing in two NCI-designated cancer centers.

Autor: Kaplan DM; Department of Behavioral and Social Sciences, Brown University, Providence, RI, USA., Hamann HA; Department of Psychology, University of Arizona, Tucson, AZ, USA., Price SN; Department of Psychology, University of Arizona, Tucson, AZ, USA., Williamson TJ; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ver Hoeve ES; Department of Psychology, University of Arizona, Tucson, AZ, USA., McConnell MH; Department of Psychiatry, Yale University, New Haven, CT, USA., Duchschere JE; Colorado Department of Human Services, Denver, CO, USA., Garland LL; Department of Medicine, University of Arizona, Tucson, AZ, USA., Ostroff JS; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Publikováno v: Journal of psychosocial oncology [J Psychosoc Oncol] 2023; Vol. 41 (1), pp. 59-75. Date of Electronic Publication: 2022 Feb 06.